We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.42B
AUM Growth
+$73.9M
Cap. Flow
-$168M
Cap. Flow %
-2.62%
Top 10 Hldgs %
14.94%
Holding
360
New
13
Increased
125
Reduced
186
Closed
9

Top Buys

Rank Stock Value
1
BMS
Bemis
BMS
+$24.1M
2
BKNG icon
Booking.com
BKNG
+$14.8M
3
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$13.5M
4
SBUX icon
Starbucks
SBUX
+$9.99M
5
TFC icon
Truist Financial
TFC
+$8.57M

Top Sells

Rank Stock Value
1
MASI
Masimo
MASI
+$19.5M
2
JWN
Nordstrom
JWN
+$14.9M
3
SLGN icon
Silgan Holdings
SLGN
+$14.2M
4
WEX icon
WEX
WEX
+$13.8M
5
CLC
Clarcor
CLC
+$13.1M

Sector Composition

Rank Sector Weight
1 Financials 19%
2 Healthcare 16.59%
3 Technology 14.75%
4 Industrials 14.19%
5 Consumer Discretionary 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSL icon
276
Carlisle Companies
CSL
$12.9B
$1.64M 0.03%
15,400
+4,300
+39% +$461K
CTRA
277
DELISTED
Coterra Energy
CTRA
$1.56M 0.02%
65,275
-1,075
-2% -$24.4K
RTX icon
278
RTX Corp
RTX
$263B
$1.54M 0.02%
21,771
+238
+1% +$16.7K
BF.A icon
279
Brown-Forman Class A
BF.A
$12.2B
$1.52M 0.02%
40,500
WMT icon
280
Walmart Inc
WMT
$858B
$1.5M 0.02%
62,346
-325,413
-84% -$7.49M
BEN icon
281
Franklin Templeton
BEN
$16.9B
$1.49M 0.02%
35,430
+6,900
+24% +$286K
DELL icon
282
Dell
DELL
$346B
$1.49M 0.02%
82,592
-76,859
-48% -$1.34M
ABBV icon
283
AbbVie
ABBV
$465B
$1.46M 0.02%
22,362
-799
-3% -$50.2K
EFX icon
284
Equifax
EFX
$19.6B
$1.43M 0.02%
10,466
+2,866
+38% +$365K
VMBS icon
285
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$1.43M 0.02%
27,223
APH icon
286
Amphenol
APH
$191B
$1.42M 0.02%
159,880
DOV icon
287
Dover
DOV
$25.5B
$1.41M 0.02%
21,727
+1,548
+8% +$98.7K
WDC icon
288
Western Digital
WDC
$149B
$1.38M 0.02%
22,160
+6,482
+41% +$372K
BSV icon
289
Vanguard Short-Term Bond ETF
BSV
$46.2B
$1.38M 0.02%
17,300
VEU icon
290
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$1.34M 0.02%
27,966
-2,500
-8% -$116K
WFC icon
291
Wells Fargo
WFC
$271B
$1.3M 0.02%
23,286
-3,412
-13% -$194K
VSM
292
DELISTED
Versum Materials, Inc.
VSM
$1.27M 0.02%
41,537
-24,157
-37% -$705K
BMY icon
293
Bristol-Myers Squibb
BMY
$130B
$1.07M 0.02%
19,745
+1,486
+8% +$81.5K
EPP icon
294
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
$1.06M 0.02%
23,650
-1,900
-7% -$81.8K
LOW icon
295
Lowe's Companies
LOW
$109B
$1.01M 0.02%
12,236
+823
+7% +$63K
GGG icon
296
Graco
GGG
$12.4B
$1M 0.02%
31,875
-225
-0.7% -$6.78K
ADBE icon
297
Adobe
ADBE
$102B
$872K 0.01%
6,698
+162
+2% +$19K
K
298
DELISTED
Kellanova
K
$866K 0.01%
12,700
WEC icon
299
WEC Energy
WEC
$33.7B
$795K 0.01%
13,113
CELG
300
DELISTED
Celgene Corp
CELG
$771K 0.01%
6,196
-369
-6% -$44.2K

Similar funds

Boston Trust Walden's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Trust Walden held 360 positions worth $6.42B, up 1.2% from $6.34B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Trust Walden's Q1 2017 filing shows 13 new, 125 increased, 186 reduced and 9 closed positions. Its largest new stake was HILL-ROM HOLDINGS, INC.: 211,542 shares worth $14.9M. The largest sale was Masimo, an estimated $19.5M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q1 2017 buy was HILL-ROM HOLDINGS, INC.: 211,542 shares worth $14.9M.
  • Boston Trust Walden added most to Bemis in Q1 2017, an estimated $24.1M increase.
  • Boston Trust Walden's biggest Q1 2017 reduction was Masimo, cutting an estimated $19.5M.
  • Boston Trust Walden fully exited Clarcor in Q1 2017, selling an estimated $13.1M.
  • Boston Trust Walden's ten largest holdings make up 15% of its $6.42B portfolio in Q1 2017.
  • Boston Trust Walden opened 13 new positions and closed 9 in Q1 2017.
  • Boston Trust Walden's portfolio value rose 1.2% quarter-over-quarter to $6.42B.

Based on Boston Trust Walden's 13F filing for Q1 2017, filed 24 Apr 2017.